Andrew J Pike is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of pharmaceutical intermediates. With a total of 2 patents, his work has implications for the development of important medicinal compounds.

Latest Patents

One of Andrew's latest patents is focused on a process for the synthesis of intermediates in the preparation of aminonitropyridines. This invention involves reacting an alkoxynitropyridine with ammonium acetate, which is crucial for creating compounds used in various therapeutic applications. Another notable patent is for 9-carbamoyl-9-(2-cyanoethyl)fluorenes, which serve as intermediates for the synthesis of 9-aminoalkyl-9-carbamoyl-fluorenes, recognized for their role as antiarrhythmic agents.

Career Highlights

Andrew J Pike is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly has allowed him to focus on innovative solutions in drug development, contributing to the advancement of healthcare.

Collaborations

Throughout his career, Andrew has collaborated with notable colleagues, including Edward R Lavagnino and Jack B Campbell. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Andrew J Pike's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical science. His work continues to impact the development of essential therapeutic agents.